about
Prospects for vaccine prevention of meningococcal infectionIgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infectionDesigning vaccines for the twenty-first century societyImmunization against a saccharide epitope accelerates clearance of experimental gonococcal infectionPhage displayed short peptides against cells of Candida albicans demonstrate presence of species, morphology and region specific carbohydrate epitopesSelection and characterization of cyclic peptides that bind to a monoclonal antibody against meningococcal L3,7,9 lipopolysaccharides.Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a.Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy.Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.Anti-idiotypic antibodies: a new approach in prion research.The unique immunological features of heparin-induced thrombocytopenia.Phages harboring specific peptides that recognize the N protein of the porcine reproductive and respiratory syndrome virus distinguish the virus from other virusesA capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.Vaccines against human diarrheal pathogens: current status and perspectivesPredicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal.Phage displayed peptides to avian H5N1 virus distinguished the virus from other virusesPhages bearing affinity peptides to bovine rotavirus differentiate the virus from other viruses.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Functional epitope core motif of the Anaplasma marginale major surface protein 1a and its incorporation onto bioelectrodes for antibody detection.Conjugate-like immunogens produced as protein capsular matrix vaccines.Identification of a conserved B-cell epitope on duck hepatitis A type 1 virus VP1 protein.Phage display for identifying peptides that bind the spike protein of transmissible gastroenteritis virus and possess diagnostic potential.A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.DNA fusion gene vaccines against cancer: from the laboratory to the clinic.Exploiting human memory B cell heterogeneity for improved vaccine efficacy.Chronic spinal cord injury impairs primary antibody responses but spares existing humoral immunity in miceMeningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.Campylobacter polysaccharide capsules: virulence and vaccines.The love-hate relationship between bacterial polysaccharides and the host immune system.Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides.Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years.Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience.BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses.Formulation of meningococcal capsular polysaccharide vaccine-loaded microparticles with robust innate immune recognition.Characterization of the Conjugation Pattern in Large Polysaccharide-Protein Conjugates by NMR Spectroscopy.In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function.A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin.An Unmutated IgM Response to the Vi Polysaccharide of Salmonella Typhi Contributes to Protective Immunity in a Murine Model of Typhoid.
P2860
Q24537338-18D37CA3-BE9F-474F-BA31-E570233BB67FQ24631904-A93B7B99-ACCA-4005-87A4-318DA2E4C67FQ27025703-691B4A37-6ADA-4EAC-B254-89372372941FQ27333895-B5DD30EE-C225-4B3C-9DD7-86EB44F605CBQ28477224-2C5B68F8-1E69-4666-8378-DA12B33F6968Q33200455-BCCD73DF-4072-41C0-8AD7-89C7304DDC0DQ33226009-8BFFE2E4-3716-4592-B53D-0A1CA237B444Q33227409-AB85DF98-104C-423C-8B2F-FC63E3E56C95Q33299645-FE27966E-C963-4AAF-9984-442AD6B7F54CQ33419724-E32F5620-CA0B-423B-8B9D-C175BC67BF9AQ33440626-6564FDDD-3D65-43F0-99D4-97988291B57DQ33541811-4007D5BE-C79A-45B7-B20D-FB9696477313Q33577932-40FDBADD-91E4-4101-B1A6-F70B3E3CFCF5Q33578045-A1D5D36C-52FE-4710-AC36-7F49AC90BAB1Q33620864-2BC205FC-2888-41E7-96C1-8DB3CAF1C879Q34009244-2B76955C-6E9B-40C5-9618-D411F9F765DFQ34097975-185A717D-17D0-401D-9672-986CF14B31F4Q34170021-C830DA6E-2096-40C0-901B-64DFDA521C16Q34200377-0C64C7E7-272F-4F1F-866D-92A3F1919A89Q35189827-224EB7EB-E11A-41F2-BB54-4205F3EB60A3Q35565708-0E33266F-3877-4335-8D2B-4025299835E6Q35642487-CAE66CE9-67E6-431B-8AF5-A708602B8DF8Q35692437-CA6CC06F-BFFE-44A8-A183-683DB43E005FQ35826392-E73CD984-6EE4-493A-87CA-CA5573F34C6AQ35928222-3D415EA8-3D32-4B02-8539-CA33F5350440Q35981021-BED8192E-3030-4BF1-BA99-BC641342A341Q36154043-98EF1C4D-8D58-4AB1-AB49-8578163FEEC8Q36159521-C77D876B-B9C2-4E3D-8FDF-4B88BF93E139Q36615936-141CAB61-30C2-4076-85A5-95F5D2C9C660Q37389041-52070446-4B3A-4542-B345-C2C95F627407Q37878485-83626339-0B89-4CAF-814C-F84B9E9D8B73Q38124392-34080951-4234-49BF-AC25-A8775D11FF46Q38367830-B8D9CE27-E71E-4C13-9738-DC156DD7B9D2Q38472786-C7CC8DAC-B2A5-4363-A77D-7E53D32BC866Q39338512-D9A6818B-212E-4788-A53E-3A44393209E3Q41986522-EBF3985F-C7F4-4795-A8CC-ECB1CA3E3F3DQ44622705-2674AA84-16AE-47AC-B6A6-1E4F1CF6AF5AQ46889693-34219A04-C73A-4EA0-89B3-7DBBDAEFB0A7Q54216843-B7AC7D83-4685-4C3C-979F-70FE649B2FE4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Novel vaccine strategies to T-independent antigens.
@ast
Novel vaccine strategies to T-independent antigens.
@en
type
label
Novel vaccine strategies to T-independent antigens.
@ast
Novel vaccine strategies to T-independent antigens.
@en
prefLabel
Novel vaccine strategies to T-independent antigens.
@ast
Novel vaccine strategies to T-independent antigens.
@en
P1476
Novel vaccine strategies to T-independent antigens.
@en
P2093
Lesinski GB
Westerink MA
P304
P356
10.1016/S0167-7012(01)00290-1
P577
2001-11-01T00:00:00Z